System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Review Epublish 33 citations

PubMed: 36901725 DOI: 10.3390/ijms24054294

Pathogenesis of Hypertension in Metabolic Syndrome: The Role of Fructose and Salt.

Int J Mol Sci 24(5)

Authors: Manoocher Soleimani, Sharon Barone, Henry Luo, Kamyar Zahedi

Affiliations

  • Research Services, New Mexico Veterans Health Care Medical Center, Albuquerque, NM 87108, USA.
  • Department of Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131, USA.

Abstract

Metabolic syndrome is manifested by visceral obesity, hypertension, glucose intolerance, hyperinsulinism, and dyslipidemia. According to the CDC, metabolic syndrome in the US has increased drastically since the 1960s leading to chronic diseases and rising healthcare costs. Hypertension is a key component of metabolic syndrome and is associated with an increase in morbidity and mortality due to stroke, cardiovascular ailments, and kidney disease. The pathogenesis of hypertension in metabolic syndrome, however, remains poorly understood. Metabolic syndrome results primarily from increased caloric intake and decreased physical activity. Epidemiologic studies show that an enhanced consumption of sugars, in the form of fructose and sucrose, correlates with the amplified prevalence of metabolic syndrome. Diets with a high fat content, in conjunction with elevated fructose and salt intake, accelerate the development of metabolic syndrome. This review article discusses the latest literature in the pathogenesis of hypertension in metabolic syndrome, with a specific emphasis on the role of fructose and its stimulatory effect on salt absorption in the small intestine and kidney tubules.

MeSH

Kidney Tubules, Hypertension, Intestine, Small, Fructose, Metabolic Syndrome

Cited by